Jennifer Nayak
Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Influenza A Virus, H1N1 Subtype | 2 | 2009 | 27 |
Why?
|
Influenza, Human | 2 | 2009 | 94 |
Why?
|
Adaptive Immunity | 1 | 2011 | 5 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2009 | 2 |
Why?
|
Chemoprevention | 1 | 2009 | 13 |
Why?
|
Viral Proteins | 1 | 2010 | 71 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2010 | 50 |
Why?
|
Antiviral Agents | 1 | 2009 | 91 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2010 | 113 |
Why?
|
T-Lymphocytes | 1 | 2011 | 182 |
Why?
|
Immunologic Memory | 2 | 2010 | 51 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2010 | 4 |
Why?
|
Autoimmune Diseases | 1 | 2011 | 49 |
Why?
|
Zanamivir | 1 | 2009 | 9 |
Why?
|
Oseltamivir | 1 | 2009 | 8 |
Why?
|
Amantadine | 1 | 2009 | 19 |
Why?
|
Spleen | 1 | 2010 | 129 |
Why?
|
Peptides | 1 | 2010 | 154 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 216 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 318 |
Why?
|
Chemokines, CXC | 1 | 2003 | 32 |
Why?
|
Child, Preschool | 1 | 2009 | 555 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 64 |
Why?
|
Humans | 3 | 2009 | 1858 |
Why?
|
Hyperoxia | 1 | 2003 | 26 |
Why?
|
Animals, Newborn | 1 | 2003 | 175 |
Why?
|
Child | 1 | 2009 | 750 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 210 |
Why?
|
Mice | 1 | 2010 | 623 |
Why?
|
Lung | 1 | 2003 | 233 |
Why?
|
Animals | 2 | 2003 | 1032 |
Why?
|
Female | 1 | 2010 | 1646 |
Why?
|
Chemokine CXCL1 | 1 | 2003 | 10 |
Why?
|
RNA, Complementary | 1 | 2003 | 12 |
Why?
|
Biological Assay | 1 | 2003 | 58 |
Why?
|
Statistics as Topic | 1 | 2003 | 133 |
Why?
|
Macrophages, Alveolar | 1 | 2003 | 44 |
Why?
|
Pulmonary Fibrosis | 1 | 2003 | 49 |
Why?
|
In Situ Hybridization | 1 | 2003 | 135 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2003 | 68 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 98 |
Why?
|
Rabbits | 1 | 2003 | 254 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 243 |
Why?
|
Oxygen | 1 | 2003 | 180 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 427 |
Why?
|
Disease Models, Animal | 1 | 2003 | 349 |
Why?
|
Time Factors | 1 | 2003 | 896 |
Why?
|
RNA, Messenger | 1 | 2003 | 394 |
Why?
|
